YEARS Clinical Decision Tool Decreases CTA in Patients with Suspected Pulmonary Embolism


Am Fam Physician. 2017 Nov 15;96(10):online.

Clinical Question

Can a simple clinical decision tool safely decrease the use of computed tomographic angiography (CTA) in patients with suspected pulmonary embolism?

Bottom Line

In this study, using a simplified algorithm in patients with suspected pulmonary embolism can safely decrease the number of CTAs. (Level of Evidence = 1b)


Over the past several years, the addition of d-dimers to emergency department laboratory panels and the widespread access of rapid diagnostic tools (i.e., CTA) have resulted in a decrease in the prevalence of pulmonary embolism to approximately 10%. These researchers from the Netherlands prospectively evaluated a simple algorithm prediction model and also compared it with the Wells prediction model in 3,465 consecutively recruited patients with suspected pulmonary embolism. The simple model (called YEARS) assesses three factors: clinical signs of deep venous thrombosis, hemoptysis, and whether pulmonary embolism is the most likely diagnosis.

In addition to a d-dimer test result, each patient was scored using the YEARS and Wells models. If a patient had no YEARS items and a d-dimer result of less than 1,000 ng per mL, the authors ruled out pulmonary embolism (1,320 patients fit this category). If a patient had no YEARS items and a d-dimer result of 1,000 ng per mL or greater, the clinician ordered a CTA (423 patients). If a patient had one or more YEARS items and a d-dimer result of less than 500 ng per mL, pulmonary embolism was ruled out (331 patients), but if the d-dimer result was 500 ng per mL or greater, the clinician ordered a CTA (1,391 patients). The researchers followed patients in whom a pulmonary embolism was ruled out for three months. Approximately 13% of the patients were diagnosed with pulmonary embolism at the outset, a handful of patients were anticoagulated for reasons other than thromboembolism (e.g., atrial fibrillation), and 18 (0.6%) of the 2,946 remaining patients were subsequently diagnosed with pulmonary embolism. Six of those were fatal. Based on the YEARS algorithm, 48% of the patients did not need a CTA compared with 34% using the Wells model.

Study design: Decision rule (validation)

Funding source: Self-funded or unfunded

Setting: Uncertain

Reference: van der Hulle T, Cheung WY, Kooij S, et al.; YEARS study group. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study [published correction appears in Lancet. 2017;390(10091):230]. Lancet. 2017;390(10091):289–297.

POEMs (patient-oriented evidence that matters) are provided by EssentialEvidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, please see http://www.essentialevidenceplus.com. Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see http://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to http://goo.gl/3niWXb.

This series is coordinated by Sumi Sexton, MD, Associate Deputy Editor.

A collection of POEMs published in AFP is available at https://www.aafp.org/afp/poems.



Want to use this article elsewhere? Get Permissions

More in AFP

Editor's Collections

Related Content

More in Pubmed


Feb 15, 2020

Access the latest issue of American Family Physician

Read the Issue

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now

Navigate this Article